Literature DB >> 23926169

Bacterial floras and biofilms of malignant wounds associated with breast cancers.

Isabelle Fromantin1, Damien Seyer, Sarah Watson, Florence Rollot, Jacqueline Elard, Marie Christine Escande, Yann De Rycke, Irène Kriegel, Véronique Larreta Garde.   

Abstract

The risk of infections and the appearance of symptoms (e.g., odors) represent the main troubles resulting from malignant wounds. The aim of this study was to characterize the balance of bacterial floras and the relationships between biofilms and bacteria and the emergence of symptoms. Experimental research was carried out for 42 days on malignant wounds associated with breast cancer. Investigations of bacterial floras (aerobes, aero-anaerobes, and anaerobes), detection of the presence of biofilms by microscopic epifluorescence, and clinical assessment were performed. We characterized biofilms in 32 malignant wounds associated with breast cancer and bacterial floras in 25 such wounds. A mixed group of floras, composed of 54 different bacterial types, was identified, with an average number per patient of 3.6 aerobic species and 1.7 anaerobic species; the presence of strict anaerobic bacterial strains was evidenced in 70% of the wounds; biofilm was observed in 35% of the cases. Odor was a reliable indicator of colonization by anaerobes, even when this symptom was not directly linked to any of the identified anaerobic bacteria. Bacteria are more likely to be present during myelosuppression and significantly increase the emergence of odors and pain when present at amounts of >10(5) · g(-1). The presence of biofilms was not associated with clinical signs or with precise types of bacteria. No infections occurred during the 42-day evaluation period. This study provides a dynamic description of the bacterial floras of tumoral wounds. The study results highlight the absolute need for new therapeutic options that are effective for use on circulating bacteria as well as on bacteria organized in biofilm.

Entities:  

Mesh:

Year:  2013        PMID: 23926169      PMCID: PMC3811619          DOI: 10.1128/JCM.01277-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Wound biofilms-are they visible?

Authors:  R J White; K F Cutting
Journal:  J Wound Care       Date:  2012-03       Impact factor: 2.072

2.  Biofilm maturity studies indicate sharp debridement opens a time- dependent therapeutic window.

Authors:  R D Wolcott; K P Rumbaugh; G James; G Schultz; P Phillips; Q Yang; C Watters; P S Stewart; S E Dowd
Journal:  J Wound Care       Date:  2010-08       Impact factor: 2.072

3.  Response to White and Cutting critique.

Authors:  J Hurlow
Journal:  J Wound Care       Date:  2012-04       Impact factor: 2.072

4.  Assessment of a wound cleansing solution in the treatment of problem wounds.

Authors:  Anneke E Andriessen; Thomas Eberlein
Journal:  Wounds       Date:  2008-06       Impact factor: 1.546

5.  Malignant wounds in women with breast cancer: feminine and sexual perspectives.

Authors:  Betina Lund-Nielsen; Kirsten Müller; Lis Adamsen
Journal:  J Clin Nurs       Date:  2005-01       Impact factor: 3.036

6.  Qualitative bacteriology in malignant wounds--a prospective, randomized, clinical study to compare the effect of honey and silver dressings.

Authors:  Betina Lund-Nielsen; Lis Adamsen; Finn Gottrup; Mikael Rorth; Anders Tolver; Hans Jorn Kolmos
Journal:  Ostomy Wound Manage       Date:  2011-07       Impact factor: 2.629

7.  Metronidazole gel in managing malodorous fungating wounds.

Authors:  Jane Clark
Journal:  Br J Nurs       Date:  2002-03

8.  Malignant fungating wounds: a survey of nurses' clinical practice in Switzerland.

Authors:  Sebastian Probst; Anne Arber; Sara Faithfull
Journal:  Eur J Oncol Nurs       Date:  2009-04-21       Impact factor: 2.398

Review 9.  Malignant fungating wounds: assessment and management.

Authors:  Caroline Dowsett
Journal:  Br J Community Nurs       Date:  2002-08

10.  Clinical identification of bacteria in human chronic wound infections: culturing vs. 16S ribosomal DNA sequencing.

Authors:  Daniel D Rhoads; Stephen B Cox; Eric J Rees; Yan Sun; Randall D Wolcott
Journal:  BMC Infect Dis       Date:  2012-11-24       Impact factor: 3.090

View more
  7 in total

1.  A Formidable Foe Is Sabotaging Your Results: What You Should Know about Biofilms and Wound Healing.

Authors:  Jenny C Barker; Ibrahim Khansa; Gayle M Gordillo
Journal:  Plast Reconstr Surg       Date:  2017-05       Impact factor: 4.730

2.  Lymphadenopathy in Fungating Extremity Soft-Tissue Sarcoma: Metastasis or Reactive?

Authors:  Nicholas M Siegel; Santiago A Lozano-Calderón; Jad M El Abiad; Carol D Morris; Adam S Levin
Journal:  Ann Surg Oncol       Date:  2021-01-03       Impact factor: 5.344

3.  Candidemia in patients with head and neck cancer: mortality and a novel risk factor.

Authors:  Kensuke Uraguchi; Takuma Makino; Shin Kariya; Youhei Noda; Hidenori Marunaka; Akira Doi; Kenichi Kozakura; Soshi Takao; Mizuo Ando
Journal:  Support Care Cancer       Date:  2022-04-06       Impact factor: 3.603

Review 4.  A Comprehensive Review of Topical Odor-Controlling Treatment Options for Chronic Wounds.

Authors:  Alma Akhmetova; Timur Saliev; Iain U Allan; Matthew J Illsley; Talgat Nurgozhin; Sergey Mikhalovsky
Journal:  J Wound Ostomy Continence Nurs       Date:  2016 Nov/Dec       Impact factor: 1.741

Review 5.  The Microbiome, Malignant Fungating Wounds, and Palliative Care.

Authors:  Mridula Vardhan; Zia Flaminio; Sakshi Sapru; Charles P Tilley; Mei R Fu; Christopher Comfort; Xin Li; Deepak Saxena
Journal:  Front Cell Infect Microbiol       Date:  2019-11-01       Impact factor: 5.293

6.  Effect of bacterium in the malignant wounds of soft tissue sarcoma.

Authors:  Eiji Nakata; Tomohiro Fujiwara; Haruyoshi Katayama; Takuto Itano; Toshiyuki Kunisada; Toshifumi Ozaki
Journal:  Oncol Lett       Date:  2022-08-17       Impact factor: 3.111

Review 7.  Antimicrobial stewardship of antiseptics that are pertinent to wounds: the need for a united approach.

Authors:  Jean-Yves Maillard; Günter Kampf; Rose Cooper
Journal:  JAC Antimicrob Resist       Date:  2021-03-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.